What is it about?
Clinical observations demonstrated that COVID-19 related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia, and prolonged prothrombin time. We suggest that C-reactive protein and prothrombin time levels present on admission in COVID-19 patients may be used as early prognostic markers of severe pneumonia requiring transfer to ICU.
Featured Image
Photo by Vladimir Fedotov on Unsplash
Why is it important?
Clinical observations demonstrated that COVID-19 related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia, and prolonged prothrombin time. The evaluation of laboratory findings including coagulation and inflammation parameters may represent a promising approach for early determination of COVID-19 severity.
Read the Original
This page is a summary of: Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia, Current Medical Research and Opinion, December 2020, Taylor & Francis,
DOI: 10.1080/03007995.2020.1853510.
You can read the full text:
Contributors
The following have contributed to this page